A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER StudyNoah M. Hahn, Hristos Z. Kaimakliotis, Woonyoung Choi et al.|European Urology|2023Cited by 58
Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatmentC. Leigh Moyer, Phuoc T. Tran, Ryan Phillips et al.|World Journal of Urology|2018Cited by 30
An Integrated Program in a Pandemic: Johns Hopkins Radiation Oncology DepartmentJean L. Wright, Akila Viswanathan, Sara R. Alcorn et al.|Advances in Radiation Oncology|2020Cited by 17
Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public WorkshopChana Weinstock, Julia A. Beaver, Daniel L. Suzman et al.|The Journal of Urology|2019Cited by 14
Stereotactic ablative radiation therapy for the treatment of oligometastatic prostate cancer.Phuoc T. Tran, Mario A. Eisenberger, C. Leigh Moyer et al.|Journal of Clinical Oncology|2017Cited by 4